UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Nonvascular VEGF Receptor 3 Expression by Corneal Epithelium Maintains Avascularity and Vision

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (30), p.11405-11410

2006

Volltextzugriff (PDF)

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth

Cancer research (Chicago, Ill.), 2007-01, Vol.67 (2), p.593-599

2007

Volltextzugriff (PDF)

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

Clinical cancer research, 2010-02, Vol.16 (4), p.1191-1205

2010

Volltextzugriff (PDF)

Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody

Neoplasia (New York, N.Y.), 2009-06, Vol.11 (6), p.594-604

2009

Volltextzugriff (PDF)

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3

Molecular cancer therapeutics, 2005-03, Vol.4 (3), p.427-434

2005

Volltextzugriff (PDF)

Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection

The Journal of biological chemistry, 2005-07, Vol.280 (28), p.26216-26224

2005

Volltextzugriff (PDF)

Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies

The Journal of biological chemistry, 2000-05, Vol.275 (19), p.14321-14330

2000

Volltextzugriff (PDF)

Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Journal of cell science, 2023-09, Vol.136 (17)

2023

Volltextzugriff (PDF)

Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes

Biotechnology and bioengineering, 2013-11, Vol.110 (11), p.2928-2937

2013

Volltextzugriff (PDF)

Backbone Flexibility of CDR3 and Immune Recognition of Antigens

Journal of molecular biology, 2014-04, Vol.426 (7), p.1583-1599

2014

Volltextzugriff (PDF)

Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2730-2730

2018

Volltextzugriff (PDF)

Abstract C159: A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.C159-C159

2013

Volltextzugriff (PDF)

Abstract A235: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.A235-A235

2013

Volltextzugriff (PDF)

Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity

mAbs, 2013-05, Vol.5 (3), p.418-431

2013

Volltextzugriff (PDF)

Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3539-3539

2012

Volltextzugriff (PDF)

Abstract C224: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.C224-C224

2011

Volltextzugriff (PDF)

The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies

Structure (London), 2011-08, Vol.19 (8)

2011

Volltextzugriff (PDF)

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Journal of cell science, 2004-06, Vol.117 (Pt 13), p.2745-2756

2004

Volltextzugriff (PDF)

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2

Journal of immunological methods, 1999-11, Vol.230 (1), p.159-171

1999

Volltextzugriff (PDF)

IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab

Human antibodies, 2010, Vol.19 (4), p.89

2010

Volltextzugriff (PDF)

Development of an alternative monoclonal antibody polishing step

Biopharm International, 2013-08, Vol.26 (8), p.S23

2013

Volltextzugriff (PDF)

Development of an alternative monoclonal antibody polishing step

Biopharm International, 2012-05, Vol.25 (5), p.34

2012

Volltextzugriff (PDF)

On the Prediction of Kidney Stone Formers

2023 IEEE International Conference on Technology Management, Operations and Decisions (ICTMOD), 2023, p.1-5

2023

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(10)
Animals
(7)
Antibodies, Monoclonal - Metabolism
(4)
Biochemistry & Molecular Biology
(4)
Ligands
(4)
Mice
(4)
Oncology
(4)
Protein Binding
(4)
Angiogenesis
(3)
Antibody
(3)
Biological And Medical Sciences
(3)
Biotechnology & Applied Microbiology
(3)
Cell Culture
(3)
Cell Proliferation
(3)
Chromatography
(3)
Design Of Experiments
(3)
Mice, Inbred Balb C
(3)
Protein Structure, Tertiary
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonvascular VEGF Receptor 3 Expression by Corneal Epithelium Maintains Avascularity and Vision

Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth

Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells

Development of a Fully Human Anti-PDGFRβ Antibody That Suppresses Growth of Human Tumor Xenografts and Enhances Antitumor Activity of an Anti-VEGFR2 Antibody

A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3

Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection

Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies

Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes

Backbone Flexibility of CDR3 and Immune Recognition of Antigens

Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Abstract C159: A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

Abstract A235: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity

Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

Abstract C224: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models

The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2

IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab

Development of an alternative monoclonal antibody polishing step

Development of an alternative monoclonal antibody polishing step

On the Prediction of Kidney Stone Formers

Aktive Filter

Suchergebnisse filtern